| Andrew Miles Overturf, MD | |
|
252 Mchenry St, Burlington, WI 53105-1828 | |
| (262) 767-6000 | |
| Not Available |
| Full Name | Andrew Miles Overturf |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 12 Years |
| Location | 252 Mchenry St, Burlington, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366708943 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 61596-20 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thedacare Regional Med Ctr - Neenah | Neenah, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Association Of Hospital Anesthesiologists Sc | 3476539875 | 70 |
News Archive
Researchers at Sandia National Laboratories have developed a super-resolution microscopy technique that is answering long-held questions about exactly how and why a cell's defenses fail against some invaders, such as plague, while successfully fending off others like E.coli.
Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company, today launched a new campaign designed to facilitate discussions around consumer genetic testing services. Called ‘DNA Conversation Starters,' Pathway will address a range of topics about genetic testing, further educating members of the media, the genetic testing community, and consumers about the benefits of genetic testing services and the depth of information obtained from Pathway's Genetic Health and Ancestry tests.
Inergetics, Inc., a leader in targeted product development for the Clinical Nutrition and Sports Supplement Markets, today announced that the Company has received a $112,500 purchase order for Resurgex Select from New Marketlink Pharmaceutical Corporation "New Marketlink."
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing and review the supplemental New Drug Application for SPRYCEL (dasatinib) for the treatment of adult patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Hearing loss is now affecting nearly 20 percent of U.S. adolescents age 12-19, a rise of 5 percent over the last 15 years, according to a new Journal of the American Medical Association (JAMA) study co-led by Ron Eavey, M.D., director of the Vanderbilt Bill Wilkerson Center and the Guy M. Maness Professor in Otolaryngology.
› Verified 9 days ago
| Entity Name | Association Of Hospital Anesthesiologists Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720076474 PECOS PAC ID: 3476539875 Enrollment ID: O20050719001050 |
News Archive
Researchers at Sandia National Laboratories have developed a super-resolution microscopy technique that is answering long-held questions about exactly how and why a cell's defenses fail against some invaders, such as plague, while successfully fending off others like E.coli.
Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company, today launched a new campaign designed to facilitate discussions around consumer genetic testing services. Called ‘DNA Conversation Starters,' Pathway will address a range of topics about genetic testing, further educating members of the media, the genetic testing community, and consumers about the benefits of genetic testing services and the depth of information obtained from Pathway's Genetic Health and Ancestry tests.
Inergetics, Inc., a leader in targeted product development for the Clinical Nutrition and Sports Supplement Markets, today announced that the Company has received a $112,500 purchase order for Resurgex Select from New Marketlink Pharmaceutical Corporation "New Marketlink."
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing and review the supplemental New Drug Application for SPRYCEL (dasatinib) for the treatment of adult patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Hearing loss is now affecting nearly 20 percent of U.S. adolescents age 12-19, a rise of 5 percent over the last 15 years, according to a new Journal of the American Medical Association (JAMA) study co-led by Ron Eavey, M.D., director of the Vanderbilt Bill Wilkerson Center and the Guy M. Maness Professor in Otolaryngology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Miles Overturf, MD 252 Mchenry St, Burlington, WI 53105-1828 Ph: (262) 767-6000 | Andrew Miles Overturf, MD 252 Mchenry St, Burlington, WI 53105-1828 Ph: (262) 767-6000 |
News Archive
Researchers at Sandia National Laboratories have developed a super-resolution microscopy technique that is answering long-held questions about exactly how and why a cell's defenses fail against some invaders, such as plague, while successfully fending off others like E.coli.
Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company, today launched a new campaign designed to facilitate discussions around consumer genetic testing services. Called ‘DNA Conversation Starters,' Pathway will address a range of topics about genetic testing, further educating members of the media, the genetic testing community, and consumers about the benefits of genetic testing services and the depth of information obtained from Pathway's Genetic Health and Ancestry tests.
Inergetics, Inc., a leader in targeted product development for the Clinical Nutrition and Sports Supplement Markets, today announced that the Company has received a $112,500 purchase order for Resurgex Select from New Marketlink Pharmaceutical Corporation "New Marketlink."
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing and review the supplemental New Drug Application for SPRYCEL (dasatinib) for the treatment of adult patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Hearing loss is now affecting nearly 20 percent of U.S. adolescents age 12-19, a rise of 5 percent over the last 15 years, according to a new Journal of the American Medical Association (JAMA) study co-led by Ron Eavey, M.D., director of the Vanderbilt Bill Wilkerson Center and the Guy M. Maness Professor in Otolaryngology.
› Verified 9 days ago
Dr. Jeffrey T. Follansbee, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 252 Mchenry St, Burlington, WI 53105 Phone: 262-763-2411 | |
Dr. Steven Ropers, Anesthesiology Medicare: Medicare Enrolled Practice Location: 709 Spring Valley Rd, Burlington, WI 53105 Phone: 262-767-6020 | |
Dr. Shailesh G. Joshi, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 252 Mchenry St, Burlington, WI 53105 Phone: 262-763-2411 | |
Dr. Robert O Ong, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 252 Mchenry St, Burlington, WI 53105 Phone: 262-763-2411 | |
Dr. Ernesto C Cababa, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 252 Mchenry St, Burlington, WI 53105 Phone: 262-763-2411 | |
Dr. Paras Bhavsar, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 252 Mchenry St, Burlington, WI 53105 Phone: 414-358-5457 |